We directly assessed the correlation of DUX4 expression to immune cell exclusion by examining CD8+ T cell abundance in the tumor microenvironment, measured by immunohistochemistry (IHC) on formalin-fixed paraffin-embedded patient tumor sections. Here, DUX4 is linked to neoplasm.